Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

COVID-19

 

Portugal’s private hospitals and state agree price for COVID-19 care

Portugal's private hospitals have agreed terms with the state to provide publicly-funded COVID-19 hospital treatment, including pathways and bundled tariffs for both minor and serious inpatient episodes. Will the market's recent high annual growth be maintained in the post-crisis period?

Covid: The double whammy – who will be left standing?

In a recent paper on the medtech outlook for Europe, UBS, looked at how Singapore and Toronto bounced back from pandemics. Pent up demand simply led to double growth rates the year after. But Covid is two things: a pandemic coupled to a steep recession, almost certainly worse than 2008. We look at what this means for a sector where private equity has often geared up to the hilt.

Booking data shows outpatient has all but stopped

Patient footfall for outpatient care across the world has all but stopped. Exclusive data from DocPlanner shows which specialities have seen the biggest drop in appointments booked and where telemedicine is really picking up some of the slack. We assess this against outpatient volumes in Singapore during SARS to see when it might pick up.

Interview: Tony Veverka, CEO, Transform

HBI talks to Tony Veverka, CEO of cosmetic surgery specialist Transform Hospital Group, about his business, and the market pre-and (speculatively) post-COVID.

COVID-19 may force re-think of German hospital ‘rationalisation’

Germany's arguably excessive hospital capacity, much of it in small regional hospitals, has proven an invaluable asset during coronavirus. A senior hospital executive tells us this may change policy conversations of the last 2-3 years around the need to trim the sector down, though paradoxically the crisis may also send the sector further into deficit.

Find Us